Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy-Reference-Cited by-同舟云学术

Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy

Published:2015-03 Issue:3 Volume:21 Page:559-564
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Othus Megan,Appelbaum Frederick R.,Petersdorf Stephen H.,Kopecky Kenneth J.,Slovak Marilyn,Nevill Thomas,Brandwein Joseph,Larson Richard A.,Stiff Patrick J.,Walter Roland B.,Tallman Martin S.,Stenke Leif,Erba Harry P.

Funder

National Cancer Institute

U.S. Department of Health and Human Services

Wyeth (Pfizer) Pharmaceuticals

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference18 articles.

1. A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia;Petersdorf;Blood,2013

2. Anthracycline dose intensification in acute myeloid leukemia;Fernandez;N Engl J Med,2009

3. Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson;Othus;Leukemia,2013

4. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study;Slovak;Blood,2000

5. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia;Cheson;J Clin Oncol,2003

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry;Oncohematology;2024-09-01

2. Second chances for secondary AML;Blood Advances;2024-08-13

3. Quantifying payloads of antibody‒drug conjugates using a postcolumn infused-internal standard strategy with LC‒MS;Analytica Chimica Acta;2024-05

4. Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?;Journal of Clinical Medicine;2024-01-18

5. Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking;Cells;2023-09-11